YD Bio Ltd (YDES)
NGM · Healthcare · Biotechnology
$5.87
-6.53%
Closing price as of 2026-10-29 · Source: TEK2day Finance
Key Metrics
Market Cap
$415.8M
Shares Outstanding
70.8M
Exchange
NGM
Currency
USD
About YD Bio Ltd
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Revenue | 350K | 510K | 597K |
| Gross Profit | 153K | 155K | 167K |
| Operating Income | (7K) | (1.5M) | (5.3M) |
| Net Income | 14K | (1.4M) | (8.3M) |
| Diluted EPS | $0.00 | N/A | N/A |